Showing results (691-700 of 1,815) with videos related to
Sort By:
Pageof 182
Transplantation and Cellular Therapy|September 27, 2020
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted GraftsYan Beauverd, Sarah Morin, Mitja Nabergoj, et al.Transplantation and Cellular Therapy|October 12, 2020
Impact of a Clostridioides Difficile Testing Computerized Clinical Decision Support Tool on an Adult Stem Cell Transplantation and Hematologic Malignancies UnitChad D Nix, William B Messer, Molly L Hale, et al.Transplantation and Cellular Therapy|October 6, 2020
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe InfectionsMaude Dumont-Lagacé, Qi Li, Mégane Tanguay, et al.Transplantation and Cellular Therapy|October 11, 2020
Negative Impact of Cytomegalovirus Reactivation on Survival in Adult Patients with Aplastic Anemia after an Allogeneic Hematopoietic Stem Cell Transplantation: A Report from Transplantation-Related Complication and Adult Aplastic Anemia Working Groups of the Japan Society for Hematopoietic Cell TransplantationKatsuto Takenaka, Yasushi Onishi, Takehiko Mori, et al.Transplantation and Cellular Therapy|October 5, 2020
Statistical Methods for Time-Dependent Variables in Hematopoietic Cell Transplantation StudiesSoyoung Kim, Brent Logan, Marcie Riches, et al.Transplantation and Cellular Therapy|October 11, 2020
Limitations of Applying the Hematopoietic Cell Transplantation Comorbidity Index in Pediatric Patients Receiving Allogeneic Hematopoietic Cell TransplantationLarisa Broglie, Jenny Ruiz, Zhezhen Jin, et al.Transplantation and Cellular Therapy|October 11, 2020
Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic LeukemiaNico Gagelmann, Rashit Bogdanov, Friedrich Stölzel, et al.Transplantation and Cellular Therapy|May 1, 2022
Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?Sonata Jodele, Christopher E Dandoy, Anthony Sabulski, et al.Transplantation and Cellular Therapy|July 13, 2022
Humoral/Cellular Immune Discordance in Stem Cell Donors: Impact on Cytomegalovirus-Specific Immune Reconstitution after Related Hematopoietic TransplantationJorge Valle-Arroyo, Aurora Páez-Vega, Raquel Fernández-Moreno, et al.Transplantation and Cellular Therapy|July 13, 2022
Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAnnalisa Ruggeri, Jacques-Emmanuel Galimard, Myriam Labopin, et al.Pageof 182